Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 23,952	$ 8,688
Prepaid expenses and other current assets	673	1,508
Other receivables	2,532	472
Total current assets	27,157	10,668
Restricted cash	4,120	5,390
Property and equipment, net	11,230	12,194
Operating lease right-of-use asset	32,884	33,911
In-process research and development	10,256	10,256
Goodwill	3,490	3,490
Other assets	813	973
Total assets	89,950	76,882
Current liabilities
Accounts payable and accrued liabilities	1,855	1,705
Accrued compensation	2,043	2,191
Convertible Loan, current	163,904
Term debt, current	77,580
Current portion of operating lease liabilities	4,622	4,564
Other current liabilities	195	487
Total current liabilities	250,199	8,947
Convertible Loan, non-current		153,860
Term debt, non-current	42,024	103,061
Operating lease liabilities, net of current portion	25,823	26,533
Deferred tax liability	3,077	3,077
Total liabilities	321,123	295,478
Commitments and contingencies (Note 12)
Stockholders' deficit
Common Stock, $0.01 par value; 217,000,000 shares authorized; 36,644,703 and 37,145,720 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	371	364
Additional paid-in capital	311,195	282,574
Accumulated deficit	(542,739)	(501,534)
Total stockholders' deficit	(231,173)	(218,596)
Total liabilities and stockholders' deficit	$ 89,950	$ 76,882